Your browser doesn't support javascript.
loading
Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase-Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy.
Zhou, Yang; Yu, Shujuan; Chen, Dan; Li, Hanlin; Xu, Peng; Yuan, Cai; Jiang, Longguang; Huang, Mingdong.
  • Zhou Y; College of Chemistry, Fuzhou University, Fuzhou, Fujian350116, P.R. China.
  • Yu S; College of Chemistry, Fuzhou University, Fuzhou, Fujian350116, P.R. China.
  • Chen D; College of Chemistry, Fuzhou University, Fuzhou, Fujian350116, P.R. China.
  • Li H; College of Chemistry, Fuzhou University, Fuzhou, Fujian350116, P.R. China.
  • Xu P; College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian350116, P.R. China.
  • Yuan C; College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian350116, P.R. China.
  • Jiang L; College of Chemistry, Fuzhou University, Fuzhou, Fujian350116, P.R. China.
  • Huang M; Fujian Key Lab Moratory of Marine Enzyme Engineering, Fuzhou University, Fuzhou, Fujian350116, P.R. China.
Mol Pharm ; 20(2): 905-917, 2023 02 06.
Article en En | MEDLINE | ID: mdl-36463525
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Activador de Plasminógeno de Tipo Uroquinasa / Neoplasias de la Mama Triple Negativas Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Activador de Plasminógeno de Tipo Uroquinasa / Neoplasias de la Mama Triple Negativas Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article